已收盤 02-06 16:00:00 美东时间
+0.690
+3.48%
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
TD Cowen analyst Hoang Nguyen maintains Upbound Group (NASDAQ:UPBD) with a Buy and lowers the price target from $31 to $30.
01-09 02:07
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
2025-11-03 20:20
Upbound Group shares are trading lower after the company reported Q3 financial ...
2025-10-31 03:38
Upbound Group (NASDAQ:UPBD) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.98 by 1.83 percent. This is a 5.26 percent increase over earnings of $0.95 per share from the
2025-10-30 19:08
Cramer says no to Remitly, prefers traditional bank. JMP Securities maintains Market Outperform for Remitly and lowers price target. Cramer dislikes Upbound Group. USA Rare Earth CEO in talks with White House. Remitly and Upbound Group shares decline, USA Rare Earth shares gain.
2025-10-07 20:49
Upbound Group (NASDAQ:UPBD) declared $0.39/share quarterly dividend, in line with previous. Forward yield 5.83% Payable Oct. 21; for shareholders of record Sept. 30; ex-div Sept. 30. See UPBD Dividend...
2025-09-18 19:26
今日重点评级关注:HC Wainwright & Co.:维持Orion Energy Sys"买入"评级,目标价从2美元升至20美元;高盛:维持Amylyx Pharmaceuticals"买入"评级,目标价从10美元升至20美元
2025-09-17 10:15
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
2025-09-16 09:48